EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Chitosan-Based Nanoparticles for Nose-to-Brain Drug Delivery: A Real Path toward Effective CNS Therapy?

Lorena R Riani iD, Gustavo F B Seno, Dominique M Silva, Cibele R Toledo, Mayara R B Paiva, Júlia S Santos, Rodrigo L Fabri, Frederico Pittella, Guilherme D Tavares

ACS Biomaterials Science & Engineering · 11.05.2026 · 12 (5) · 2567-2589

DOI: 10.1021/acsbiomaterials.6c00137 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ACS Biomaterials Science & Engineering, online erschienen am 23.04.2026. Verfasst von Lorena R Riani und 8 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Program in Pharmaceutical Science, Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais 36036-900, Brazil. Hauptthemen laut MEDLINE: Chitosan, Nanoparticles, Central Nervous System Diseases, Nasal Mucosa. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 193 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Treating central nervous system (CNS) disorders remains a major clinical challenge. The blood-brain barrier (BBB), systemic toxicity, and first-pass metabolism are key obstacles. These factors limit the effective drug delivery to the brain. Intranasal administration has emerged as a noninvasive strategy to bypass the BBB. This approach enables direct drug delivery to the brain through the olfactory and trigeminal nerve pathways, commonly referred to as nose-to-brain (N2B) delivery. In this context, chitosan (CS), a biocompatible and mucoadhesive polysaccharide with permeation-enhancing properties, has gained significant interest as a functional material for nanoparticle (NP) engineering. CS-based or CS-coated NP can prolong the residence time on the nasal mucosa and facilitate drug transport to the CNS. This review provides a comprehensive overview of recent advances in CS-based NP for N2B drug delivery across a range of CNS disorders, including neurodegenerative, neuropsychiatric, neoplastic, and infectious conditions. Particular attention is given to formulation strategies, mechanistic insights, and preclinical outcomes. Recent patent applications are surveyed to underscore the translational potential and commercial interest in this technology. Collectively, CS-based NPs effectively address major therapeutic barriers, establishing a transformative and innovative platform in CNS drug delivery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChitosanNanoparticlesCentral Nervous System DiseasesNasal MucosaDrug Delivery SystemsBrainDrug CarriersHumansAnimalsAdministration, IntranasalBlood-Brain Barrier

Stichwörter der Autor:innen

CNS disorderschitosanintranasal deliverynanoparticlesnose-to-brain

Substanzen

ChitosanDrug Carriers

Autor:innen und Institutionen

  • Postgraduate Program in Pharmaceutical Science, Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais 36036-900, Brazil.
  • Faculty of Pharmacy, Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais 36036-900, Brazil.
  • Department of Pharmacology, Institute of Biological Sciences, Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais 36036-900, Brazil.
  • Department of Biochemistry, Institute of Biological Sciences, Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais 36036-900, Brazil.

ORCID-Profile: Lorena R Riani

Förderung

  • Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior

Zitieren

APA

Riani, L. R., Seno, G. F. B., Silva, D. M., Toledo, C. R., Paiva, M. R. B., Santos, J. S., Fabri, R. L., Pittella, F., & Tavares, G. D. (2026). Chitosan-Based Nanoparticles for Nose-to-Brain Drug Delivery: A Real Path toward Effective CNS Therapy?. ACS Biomaterials Science & Engineering, 12(5), 2567-2589. https://doi.org/10.1021/acsbiomaterials.6c00137

Vancouver

Riani LR, Seno GFB, Silva DM, Toledo CR, Paiva MRB, Santos JS, et al. Chitosan-Based Nanoparticles for Nose-to-Brain Drug Delivery: A Real Path toward Effective CNS Therapy?. ACS Biomaterials Science & Engineering. 2026;12(5):2567-2589. doi:10.1021/acsbiomaterials.6c00137

BibTeX
@article{Riani2026,
  author = {Riani, Lorena R and Seno, Gustavo F B and Silva, Dominique M and Toledo, Cibele R and Paiva, Mayara R B and Santos, Júlia S and Fabri, Rodrigo L and Pittella, Frederico and Tavares, Guilherme D},
  title = {Chitosan-Based Nanoparticles for Nose-to-Brain Drug Delivery: A Real Path toward Effective CNS Therapy?},
  journal = {ACS Biomaterials Science & Engineering},
  year = {2026},
  volume = {12},
  number = {5},
  pages = {2567--2589},
  doi = {10.1021/acsbiomaterials.6c00137}
}
Kostenlos starten →